Evidence map›Paper›PMID 41689517›Full record

ArticleJournal of the American Chemical Society2026

The Catalytic Asymmetric Mukaiyama-Michael Reaction of Silyl Ketene Acetals with Cyclic Enones: Short Routes to Jasmonates.

Ruigang Xu, Hui Zhou, Han Yong Bae, Vijay N Wakchaure, Lorenzo Baldinelli, Isaac F Leach, Giovanni Bistoni, Philip Kraft, Benjamin List

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruigang XuMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, 45470 Mülheim an der Ruhr, Germany.ORCID 0009-0002-5345-2994
Hui ZhouCollege of Chemistry, Central China Normal University, Wuhan 430079, P. R. China.ORCID 0000-0001-7474-203X
Han Yong BaeDepartment of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID 0000-0002-7559-7919
Vijay N WakchaureMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, 45470 Mülheim an der Ruhr, Germany.
Lorenzo BaldinelliDepartment of Chemistry, Biology, and Biotechnology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0002-0279-2094
Isaac F LeachDepartment of Chemistry, Biology, and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Giovanni BistoniDepartment of Chemistry, Biology, and Biotechnology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-4849-1323
Philip KraftSymrise AG, S&C Global Innovation Fragrances, Building D 209, Mühlenfeldstr. 1, 37603 Holzminden, Germany.ORCID 0000-0002-4801-5389
Benjamin ListMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, 45470 Mülheim an der Ruhr, Germany.ORCID 0000-0002-9804-599X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A silylium imidodiphosphorimidate (IDPi) Lewis acid catalyst enables a broadly applicable organocatalytic asymmetric Mukaiyama-Michael addition of moderately electrophilic cycloenones with enol silanes, affording 1,4-adducts in up to 98% yield and >99:1 e.r. At 0.05 mol % catalyst loading, the reaction scales to 167 g of product with 96% catalyst recovery. The method accommodates a wide range of enones and silylated nucleophiles, allowing streamlined access to key jasmonates and related valuable targets. Computational studies elucidated the origin of the enantioselectivity in this reaction. This platform thus provides a versatile entry to structurally complex chiral scaffolds with direct relevance to plant signaling, fragrance chemistry, aromatherapy, and pharmaceutical sciences.

Identifiers

PMID41689517
PMCPMC12951435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.